10.92 USD
↘ 0.45 (3.96%)AT CLOSE (03:59 PM EST)
Shares of Janux Therapeutics, Inc. Common Stock (JANX) are trading at $10.92. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. JANX is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Nov 16, 2026.